Background and aims: Factors that increase the risk of reduced neurocognitive outcomes for children following treatment for CNS tumours include treatment protocol, age at diagnosis, presence and duration of hydrocephaly, time post-treatment, and tumour location. The aim of the study was to assess the language outcomes of a child presenting with a heightened risk of reduced language outcomes following risk-adapted treatment at the age of 4 years 8 months for ependymoma located on the cerebellar midline. Method: Baseline assessment of general language skills and more complex higher-level language skills was undertaken at the age of 7 years 7 months. Follow-up language assessment was undertaken 18 months later. Change in performance scores ove...
The general language skills of 13 children (mean age: 8; 2 years) treated with a central nervous sys...
Recent advances in the delivery of cranial radiation therapy aim to reduce the adverse neurocognitiv...
Twenty children who had been treated for posterior fossa tumour at least 12 months before the presen...
The language skills of 4 children treated for tumors involving the cerebellum and/or fourth ventricl...
Background/Aims: Childhood-acquired cerebellar studies to date have appeared to present a concordant...
Background. To date few studies have investigated the impact of management for supratentorial tumour...
Objective: Recent research findings suggested that children treated for medulloblastoma (MB) may exp...
Young children with brain tumours are at high risk of developing treatment-related sequelae. We aime...
Twenty children who had been treated for posterior fossa tumour at least 12 months prior to their in...
The preliminary findings of a prospective study aimed at investigating changes in the language abili...
Background. Limited information is available regarding the impact of childhood tumour on the cerebra...
Up to 85% of children treated for brain tumor survive beyond five years; hence optimizing quality of...
Background: Current treatment approaches for pediatric ependymoma differ between North American and ...
Purpose: Brain tumors and associated treatments in children have been shown to cause long term neuro...
Abstract Background To investigate the neuropsychological outcome of children treated with surgery a...
The general language skills of 13 children (mean age: 8; 2 years) treated with a central nervous sys...
Recent advances in the delivery of cranial radiation therapy aim to reduce the adverse neurocognitiv...
Twenty children who had been treated for posterior fossa tumour at least 12 months before the presen...
The language skills of 4 children treated for tumors involving the cerebellum and/or fourth ventricl...
Background/Aims: Childhood-acquired cerebellar studies to date have appeared to present a concordant...
Background. To date few studies have investigated the impact of management for supratentorial tumour...
Objective: Recent research findings suggested that children treated for medulloblastoma (MB) may exp...
Young children with brain tumours are at high risk of developing treatment-related sequelae. We aime...
Twenty children who had been treated for posterior fossa tumour at least 12 months prior to their in...
The preliminary findings of a prospective study aimed at investigating changes in the language abili...
Background. Limited information is available regarding the impact of childhood tumour on the cerebra...
Up to 85% of children treated for brain tumor survive beyond five years; hence optimizing quality of...
Background: Current treatment approaches for pediatric ependymoma differ between North American and ...
Purpose: Brain tumors and associated treatments in children have been shown to cause long term neuro...
Abstract Background To investigate the neuropsychological outcome of children treated with surgery a...
The general language skills of 13 children (mean age: 8; 2 years) treated with a central nervous sys...
Recent advances in the delivery of cranial radiation therapy aim to reduce the adverse neurocognitiv...
Twenty children who had been treated for posterior fossa tumour at least 12 months before the presen...